Statistics

Total Visits

Views
Lurbinectedin (PM01183) activity in BRCA1/2-associated or unselected metastatic breast cancer. Interim results of an ongoing phase II trial83

Select a period of time:

Number of views in the range

Views
Lurbinectedin (PM01183) activity in BRCA1/2-associated or unselected metastatic breast cancer. Interim results of an ongoing phase II trial16

Views

Views
October 20250
November 20254
December 20252
January 20262
February 20260
March 20266
April 20262
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States6
Uruguay2
Brazil1
Chile1
Colombia1
Spain1
United Kingdom1
Greece1
Mexico1
Turkey1
 

Top cities views

Views
Athens1
Bogotá1
Chicago1
Istanbul1
Montevideo1
Paine1
Rio de Janeiro1
Santiago de Compostela1